Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The common femoral vein (CFV) is a large blood vessel located within the femoral triangle of the groin and serves as the primary site for femoral venous access [1, 2]. It is a critical anatomical structure used by clinicians to establish central venous access for administering intravenous fluids, medications, and parenteral nutrition, as well as for performing hemodialysis and emergency resuscitation [3, 4, 6]. While the site provides a rapid and predictable route for vascular entry—especially when internal jugular or subclavian access is unavailable—it is associated with clinical risks such as deep vein thrombosis (DVT) and catheter-related bloodstream infections [6, 8]. Importantly, the femoral venous access site is a clinical and anatomical landmark rather than a therapeutic target molecule such as a receptor, enzyme, or transporter [1, 5]. It does not possess a specific pharmacological mechanism of action, as its role in medicine is purely as a procedural conduit for systemic delivery [7, 9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Common femoral vein (CFV).